Study on the medication law and action mechanism of tic disorder patent compound based on data mining and network pharmacology
WANG Xiaoran1 ZHENG Pan2 SUN Shijie1
1.Basic Medical College, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450046, China;
2.Prescription Discipline, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450046, China
Abstract：Objective To explore the medication rule and action mechanism of tic disorder patent compound based on data mining and network pharmacology. Methods The patent compound prescription for the treatment of tic disorder in the China National Knowledge Infrastructure and the China National Intellectual Property Administration Patent Datebase was searched by computer, and the time limit was to build the database until December 31, 2020. The regularity of drug use was analyzed by SPSS 21.0 and SPSS Modeler 18.0 software. The active components of core drugs and the effective targets of the interaction between drug targets and disease targets were screened by traditional Chinese medicine systems pharmacology database and analysis platform, GeneCards, DrugBank and OMIM database, and the target protein names were standardized with the help of Uniprot database. The “drug-active ingredient-target” network was screened and constructed by Cytoscape 3.7.0 software, and the effective targets were introduced into STRING platform to draw PPI network. GO enrichment analysis and KEGG signal pathway analysis of intersection target were carried out by Metascape. Results A total of 93 patented prescriptions were collected, involving 243 traditional Chinese medicines, mainly using drugs for calming the liver and relieving wind and tonifying deficiency, and the top five core drugs were Rhizoma Gastrodia, Radix Paeoniae Alba, gambir plant nod, Poria and Rhizoma Aoori Tatarinowii. A total of 16 core drug pairs were obtained by correlation analysis. Five kinds of drug combinations were obtained by systematic clustering. A total of 79 active components and 372 action targets of the core drug, 1259 disease targets and 137 effective targets were screened. GO analysis showed 20 biological processes such as chemical synaptic transmission and ion transport, six cellular components such as presynaptic membrane and vesicle lumen, 12 molecular functions such as G protein coupled receptor binding and receptor ligand activity, and 12 signal pathways such as neuroactive ligand-receptor interaction and cAMP signal pathway by KEGG analysis. Conclusion The treatment of tic disorder with traditional Chinese medicine patent compound prescription takes calming the liver and extinguishing wind as the core, taking into account the deficiency of liver and kidney, and the core drugs can treat tic disorders through multi-components, multi-targets and multi-pathways.
王笑冉1 郑攀2 孙世杰1. 基于数据挖掘和网络药理学探究抽动障碍专利复方的用药规律与作用机制[J]. 中国医药导报, 2021, 18(29): 18-24.
WANG Xiaoran1 ZHENG Pan2 SUN Shijie1. Study on the medication law and action mechanism of tic disorder patent compound based on data mining and network pharmacology. 中国医药导报, 2021, 18(29): 18-24.
[1] 刘智胜，秦炯，王家勤，等.儿童抽动障碍诊断与治疗专家共识（2017实用版）[J].中华实用儿科临床杂志，2017， 32（15）：1137-1140.
[2] Liu ZS，Cui YH，Sun D，et al. Current Status，Diagnosis，and Treatment Recommendation for Tic Disorders in China [J]. Front Psychiatry，2020，11：774.
[3] Tagwerker GF，Walitza S. Tic Disorders and Tourette Syndrome：Current Concepts of Etiology and Treatment in Children and Adolescents [J]. Neuropediatrics，2016，47（2）：84-96.
[4] 杨翠玲，张肖瑾，赵琼，等.儿童多发性抽动症的中医认识及治疗概况[J].中国中西医结合儿科学，2020，12（4）：277-280.
[5] 高汉媛，史正刚.多发性抽动症发病机制探讨[J].卫生职业教育，2016，34（9）：157-159.
[6] Patel H，Nguyen K，Lehman E，et al. Use of Complementary and Alternative Medicine in Children With Tourette Syndrome [J]. J Child Neurol，2020，35（8）：512-516.
[7] Qi H，Liu R，Zheng W，et al. Efficacy and safety of traditional Chinese medicine for Tourette’s syndrome：A meta-analysis of randomized controlled trials [J]. Asian J Psychiatr，2020，47：101853.
[8] 国家药典委员会.中华人民共和国药典[S].一部.北京：中国医药科技出版社，2015.
[9] Li J， Zhao P，Tian Y，et al. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease [J]. Sci Rep，2015，5：15290.
[10] The UniProt Consortium. UniProt： a worldwide hub of protein knowledge [J]. Nucleic Acids Res，2019，47：D506-D515.
[11] Maia TV，Conceicao VA. Dopaminergic Disturbances in Tourette Syndrome：An Integrative Account[J]. Biol Psychiatry，2018，84（5）：332-344.
[12] 万朋，金清华.多巴胺及其受体在中枢神经系统的作用研究进展[J].武汉大学学报：医学版，2017，38（1）：169-172.
[13] Kanaan AS，Gerasch S，García-García I，et al. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome [J]. Brain ，2017，140（1）：218-234.
[14] Kumar A，Duda L，Mainali G，et al. A Comprehensive Review of Tourette Syndrome and Complementary Alternative Medicine [J]. Curr Dev Disord Rep，2018，5（2）：95-100.
[15] Takemori H，Kajimura J，Okamoto M. TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain [J]. Febs J，2007，274（13）：3202-3209.
[16] Meng C，Zhang JC，Shi RL，et al. Inhibition of interleukin-6 abolishes the promoting effects of pair housing on post-stroke neurogenesis [J]. Neuroscience，2015， 307：160-170.
[17] Tran HP，Shin E，Saito K，et al. Protective potential of IL-6 against trimethyltin-induced neurotoxicity in vivo [J]. Free Radic Biol Med，2012，52（7）：1159-1174.
[18] 韩娜，刚宝芝.阿尔茨海默病退行性病变和血管因素复合损伤及血管内皮生长因子的作用[J].医学综述，2012， 18（17）：2740-2743.
[19] Takahashi，Fukushima，Tomita，et al. Tumor necrosis factor α negatively regulates the retrieval and reconsolidation of hippocampus-dependent memory [J]. Brain Behav Immun，2021，2：33.
[20] 潘玲珍，闫智勇，左长英，等.长期使用地西泮对神经活性配体受体相互作用信号通路的影响[J].中国药科大学学报，2011，42（5）：443-446.
[21] Su SY，Hsieh CL，Wu SL，et al. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo [J]. J Ethnopharmacol，2009，123（1）：68-73.
[22] 贾润梅，图雅，王育民.抽动障碍中枢神经递质失衡发病机制的研究进展[J].中国医药科学，2020，10（21）：45-48.
[23] 杨琰茗，杨雅清，宋杲，等.腺苷酸环化酶的研究进展[J].临床与病理杂志，2019，39（2）：390-394.
[24] 王丽霞，赵林，曹娜，等.多发性抽动症的免疫学研究概述[J].世界最新医学信息文摘，2017，17（45）：31-32.
[25] Li E，Ruan Y，Chen Q，et al. Streptococcal infection and immune response in children with Tourette’s syndrome [J]. Childs Nerv Syst，2015，31（7）：1157-1163.
[26] Martino D，Zis P，Buttiglione M. The role of immune mechanisms in Tourette syndrome [J]. Brain Res，2014，1617：126-143.
京公网安备 11010502046598号